Perceptions,Social Representations and Experience of Lyme Borreliosis and Ticks in Adolescents Likely to be Infected and Their Parents

NCT05678478 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 5

Last updated 2024-07-24

No results posted yet for this study

Summary

the study is offered to adolescents aged 12 to 17 and their families suspected of or suffering from Lyme barilliosis.

During inclusion, three interviews will be carried out for each family. This choice of the number of interviews per family seems the most appropriate to have a plurality of answers to the questions asked. Thus, these will have a duration of 30 min to 1 hour and will be carried out by an anthropologist. The first interview will be with the teenager. The second interview will then concern the parent(s). Finally, the last appointment will be with the teenager and his parents.

Conditions

  • Lyme Disease

Interventions

OTHER

semi-directed interview concerning the experience of adolescents and their parents on Lyme borreliosis and on the tick.

semi-structured interview on the experience of adolescents and their parents on Lyme borreliosis and the tick. The interviews will be semi-directed in physical presence. Three interviews will be conducted. The minor will be questioned first, then the parent(s). And finally, the whole family in one interview. All interviews will be audio recorded with parallel note taking in order to best transcribe the visual expressions. The interviews will be transcribed in writing and pseudonymised.

Sponsors & Collaborators

  • Centre Hospitalier Intercommunal Creteil

    lead OTHER

Eligibility

Min Age
12 Years
Max Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-02-01
Primary Completion
2023-06-20
Completion
2023-06-20

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05678478 on ClinicalTrials.gov